Top 50 Life Science Angel Investors in United States (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Sahin Boydas
Angel
|
6 | United States, Mexico, Norway | Seed, Series A, Series B | Software, Financial Services, Information Technology | $500k–$150M |
|
bumpkins profile
Angel
|
4 | United States, Canada, India | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Robotics | $325k–$57M |
|
Milad Alucozai
Angel
|
4 | United States, Canada, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Medical | $110k–$60M |
|
Erik Peterson
Angel
|
3 | United States, Canada, Algeria | Seed, Equity Crowdfunding, Series A | Software, Biotechnology, SaaS | $69k–$20M |
|
Esther Dyson
Angel
|
3 | United States, Canada, Russian Federation | Seed, Series A | Health Care, Software, Medical | $270k–$16M |
|
Kevin Moore
Angel
|
3 | United States, India, Canada | Seed, Pre-Seed, Angel | Software, Health Care, E-Commerce | $120k–$5.2M |
|
Chris Gibson
Angel
|
3 | United States, France, Switzerland | Series A, Seed | Biotechnology, Health Care, Life Science | $4.9M–$55M |
|
Darian Shirazi
Angel
|
3 | United States, Germany, Canada | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $2M–$100M |
|
John Ballantyne
Angel
|
2 | United States | Seed, Series A, Angel | Biotechnology, Health Care, Life Science | $4.5M–$30M |
|
Jay Zaveri
Angel
|
2 | United States, Japan, Canada | Seed, Series A | Biotechnology, Health Care, Software | $1M–$25M |
|
Nat Turner
Angel
|
2 | United States, China, Colombia | Seed, Series A, Series B | Health Care, Software, Medical | $1.5M–$36M |
|
Katie Haun
Angel
|
2 | United States, United Kingdom | Seed, Series A | Blockchain, Financial Services, FinTech | $4.5M–$200M |
|
Kevin Mahaffey
Angel
|
2 | United States, Canada, Israel | Seed, Series A, Pre-Seed | Software, SaaS, Artificial Intelligence | $1.3M–$30M |
|
Peter Harris
Angel
|
2 | United States | Seed | Life Science, Biotechnology, Health Diagnostics | $2.4M–$5M |
|
Mei Z.
Angel
|
2 | United States, United Kingdom, Singapore | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Information Technology | $1M–$156M |
|
Ankit Jain
Angel
|
2 | United States | Seed, Pre-Seed | Health Care, Medical, Hospital | $75k–$3.5M |
|
Lars Fjeldsoe-Nielsen
Angel
|
2 | United States, Denmark, United Kingdom | Seed, Series A, Series B | Software, Information Technology, Mobile Apps | $1.8M–$163M |
|
CJ Reim
Angel
|
2 | United States | Series A, Seed, Series D | Robotics, E-Commerce, SaaS | $3.7M–$150M |
|
Zach Weinberg
Angel
|
2 | United States, Israel, United Kingdom | Seed, Series A, Pre-Seed | Software, Health Care, SaaS | $1.4M–$30M |
|
Joe Betts-Lacroix
Angel
|
2 | United States | Seed | Life Science, Biotechnology, Pharmaceutical | $3.6M–$4.3M |
|
Patrick Collison
Angel
|
2 | United States, United Kingdom, Ireland | Series A, Seed, Series C | Software, Artificial Intelligence, Information Technology | $2.7M–$170M |
|
Patrick Yang
Angel
|
2 | United States | Series A, Seed, Series B | Software, Health Care, Artificial Intelligence | $2.5M–$50M |
|
Alec Nielsen
Angel
|
2 | United States, Germany | Seed, Pre-Seed | Biotechnology, Biopharma, Medical | $3M–$16M |
|
Sridhar Iyengar
Angel
|
2 | United States | Seed, Angel, Pre-Seed | B2B, Events, Travel | $470k–$3M |
|
Jonathan Milner
Angel
|
2 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
Craig Mundie
Angel
|
2 | United States | Seed, Series B, Series C | Life Science, Chemical, Genetics | |
|
Avichal Garg
Angel
|
2 | United States, Canada, Mexico | Seed, Series A | Software, Blockchain, Internet | |
|
David R. Walt
Angel
|
2 | United States | Seed, Series A, Series B | Biotechnology, Genetics, Life Science | |
|
Joshua Elkington
Angel
|
2 | United States | Seed | Biopharma, Life Science, Biotechnology | $2.6M–$2.6M |
|
Aiden Ross
Angel
|
2 | United States | Seed, Pre-Seed | Consulting, Life Science, Neuroscience | |
|
Jeff Dean
Angel
|
2 | United States, United Kingdom, Japan | Seed, Series A, Pre-Seed | Artificial Intelligence, Information Technology, Software | $450k–$60M |
|
Brian S. Cohen
Angel
|
2 | United States, Israel | Seed, Series A | Software, SaaS, Mobile | $300k–$12M |
|
Sujay Jaswa
Angel
|
2 | United States, Spain, Germany | Seed, Series B, Series A | Software, FinTech, Financial Services | $1.8M–$200M |
|
Balaji Srinivasan
Angel
|
2 | United States, India, Singapore | Seed, Pre-Seed, Series A | Blockchain, Software, Cryptocurrency | $665k–$31M |
|
Michael Chambers
Angel
|
2 | United States | Series A | Biotechnology, Genetics, Life Science | $30M–$55M |
|
James Hong
Angel
|
2 | United States | Seed, Series A, Angel | E-Commerce, Mobile, Internet | $100k–$25M |
|
Nitesh Banta
Angel
|
2 | United States, Canada, India | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $500k–$24M |
|
Elad Gil
Angel
|
2 | United States, United Kingdom, Israel | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $1.6M–$117M |
|
Mark Cuban
Angel
|
1 | United States, United Kingdom, Singapore | Seed, Series A | Software, Artificial Intelligence, Blockchain | |
|
Vinny Lingham
Angel
|
1 | United States, South Africa, United Kingdom | Seed, Angel | Blockchain, Internet, Cryptocurrency | |
|
Aaron Levie
Angel
|
1 | United States, Czech Republic | Seed, Series A, Series B | Software, FinTech, Financial Services | |
|
Ethan Oren Perlstein
Angel
|
1 | United States, Canada | Seed | Biotechnology, Cannabis, Biopharma | |
|
Alice Zhang
Angel
|
1 | United States, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Medical | |
|
Daniel M. Bradbury
Angel
|
1 | United States | Seed, Series A | Biotechnology, Health Care, Life Science | |
|
Paul Manning
Angel
|
1 | United States | Series A, Series B, Post-IPO Equity | Biotechnology, Therapeutics, Medical | |
|
Angela Jackson
Angel
|
1 | United States | Convertible Note, Series A | Local, Internet, Software | |
|
Willard Umphrey
Angel
|
1 | United States | Seed | Analytics, Life Science, Biotechnology | |
|
Norman Sorensen
Angel
|
1 | United States | Seed | SaaS, FinTech, Analytics | |
|
Leonardo DiCaprio
Angel
|
1 | United States, Israel, Switzerland | Series A, Seed | Food and Beverage, Food Processing, Manufacturing | |
|
Noel Hall
Angel
|
1 | Canada, United States | Seed, Angel | Biotechnology, Genetics, Life Science | |
| Access all 335 angel investors in United States Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Sahin Boydas is the PEF Chapter Lead of PEF Community. He previously worked at RemoteTeam.com as CEO and Founder. Sahin Boydas attended Koç University, where he took a Bachelor of Science in Computer Engineering, and Bahcesehir University, where he took a Master of Business Administration in Entrepreneurship.
Show more...Investment focus
- Industry: Software, Financial Services, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Mexico, Norway
Investor stats
- Total investments: 247
- Round size: Seed $500k–$15M; Series A $7M–$35M; Series B $23M–$150M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Seezo — Seezo provides security design reviews for every feature a company builds, leveraging Gen AI to scale threat modeling. The platform helps developers ship features faster by identifying potential risks and vulnerabilities. Seezo focuses on application security (AppSec) and aims to integrate security seamlessly into the development process.
- Neurable — Neurable develops software to understand human intent by using advanced machine learning techniques to classify the electrical signals produced by your brain. Neurable's software turns these biometric signals into actionable insights for measuring emotion and providing control of connected devices.
- Reliable Robotics — Advanced automation will make aircraft safer, more available, more affordable and fundamentally transformative to the way goods and people move around the planet.
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Robotics
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 49
- Round size: Seed $2.3M–$9.1M; Pre-Seed $325k–$2M; Series A $10M–$57M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
- MightyFly — MightyFly is enabling worldwide access to goods with fast, on-demand delivery services for businesses and consumers. We’re putting the infrastructure in place to connect remote locations together with long range, heavy cargo aircraft. Many areas in the world today suffer from an inability to obtain critical and often urgently needed goods andsupplies at an affordable cost. Our goal at MightyFly is to solve this problem through express, customized aerial drone delivery services. MightyFly drones will transport cargo to multiple locations in a single flight across hundreds of miles of remote terrain that is difficult if not impossible to cross with trucks or other ground vehicles. We are developing vertical-takeoff-and-landing (VTOL) drones that fly more than 300 miles, and carry payloads in excess of 50 pounds at a fraction of the cost of helicopters. Featuring automated cargo loading and unloading, and requiring no launch or recovery infrastructure, MightyFly drones will accommodate ad-hoc deliveries to undeveloped sites as well as servicing locations along established routes.
- Bear Flag Robotics — Safe, productive and efficient farming operations for the next generation of growers. Customize, Orchestrate, Automate,and Scale your fleet to your needs.
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 54
- Round size: Seed $150k–$6.7M; Pre-Seed $110k–$5M; Series A $13M–$60M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Erik Peterson is the Founder at DormTrader.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Seed, Equity Crowdfunding, Series A
- Geography: United States, Canada, Algeria
Investor stats
- Total investments: 60
- Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
- Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
- Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Esther Dyson - Founder @ Way to Wellville
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A
- Geography: United States, Canada, Russian Federation
Investor stats
- Total investments: 72
- Round size: Seed $270k–$4.3M; Series A $1.5M–$16M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- The Beans — The Beans offers a software application platform that creates personalized cash flow plans designed for its users. The Beans is Simplifying the path to financial balance through design and technology so that people can focus on what they love.
- NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
- Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, India, Canada
Investor stats
- Total investments: 99
- Round size: Seed $190k–$5.2M; Pre-Seed $120k–$3.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
- Trace —
- Augmend — Create documentation and an AI assistant from any video.
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Seed
- Geography: United States, France, Switzerland
Investor stats
- Total investments: 10
- Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Inato — Inato matches the right sites to the right clinical research study, globally.
- Known Medicine — Known Medicine is looking to take the experimentation of how tumors respond to cancer drugs out of the patient’s body and into the lab. The startup breaks down tumor samples into micro tumors, which they treat separately inside specialized micro-environments with different methods and see what works best.
- Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Darian Shirazi is the Managing Partner of Gradient.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 177
- Round size: Seed $2M–$10M; Series A $6.3M–$30M; Series B $22M–$100M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- SolveAI —
- Rowspace — Rowspace provides an AI platform for financial institutions to make decisions using proprietary data. The platform focuses on organizing, processing, and analyzing internal datasets alongside market information. It applies artificial intelligence and machine learning techniques tailored to financial workflows. Rowspace supports use cases such asinvestment research, risk analysis, and product strategy. The company works with financial services firms that want to operationalize data for day-to-day and strategic decisions.
- Harmattan AI — Building the Future of Autonomous Warfare.
John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Officer since its establishment. His innovative work at Aldevron includes creation of the GMP Source product line and collaborative research with military scientists in the development of vaccine andpassive-based countermeasures to lethal and potentially weaponized viral hemorrhagic threats such as Ebola, Marburg and some hantavirus family members. He leads the research and development team at Aldevron which develops new methods and products through internal programs, collaborations, and technology licensing. John sees the advances in biotechnology providing opportunities for Agathos to enable ethical pharmaceutical development that will benefit patients, employees, and society. Ballantyne received undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. After beginning graduate school in New Zealand he transferred to the United States in 1994 and completed his Ph.D. in Pharmaceutical Sciences at North Dakota State University.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Seed, Series A, Angel
- Geography: United States
Investor stats
- Total investments: 11
- Round size: Seed $4.5M–$7M; Series A $12M–$30M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- CureLab Oncology —
- SmartWorx — SmartWorx is an AI-native, no-code enterprise platform that redefines how organizations build, integrate, and scale business applications. Powered by a metadata-driven architecture, SmartWorx leverages multi-agent AI to dynamically build applications, configure the platform itself, or be applied directly to an organization’s own data. The result isa unified environment that replaces fragmented ERP, CRM, and ITSM systems with extensible, real-time solutions supported by a marketplace of pre-built apps and integrations. Designed for both commercial and government use, SmartWorx enables rapid innovation, interoperability, and compliance at scale—empowering enterprises to transform how software is created and adapted.
- Curelab Veterinary —
Jay Zaveri is based out of Menlo Park, California, and is the President and Board of Directors of Aether Bio and Founder and Partner of Natural Capital.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United States, Japan, Canada
Investor stats
- Total investments: 68
- Round size: Seed $1M–$4M; Series A $3M–$25M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- BitClout — BitClout is a platform owned by its users. Bitcoin is decentralizing money, BitClout is decentralizing social media.
- Litterati — Litterati is an app that encourages users to pick up and track litter.The app plans to let users join groups, so that schools, clubs, and other communities can track their collective efforts rather than having to go solo. It will also introduce maps, so litter-pickers can see what else is being picked up in their neighborhoods.
- Kingdom — Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones.They workwith clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Nat Turner is based out of New York, New York, and is the CEO and Chairman of Collectors. Nat previously worked at OneOncology as a board member. Nat Turner attended the Wharton School of the University of Pennsylvania.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, China, Colombia
Investor stats
- Total investments: 75
- Round size: Seed $1.5M–$5.5M; Series A $3M–$23M; Series B $5M–$36M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
- Collectors — The infrastructure that powers trust, security, and opportunity in collectibles.
- Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Katie is the founder and CEO of Haun Ventures, a Silicon Valley venture fund that manages billions in investments across frontier technologies including blockchain and digital assets. The firm’s institutional investors are major sovereign wealth funds, endowments, foundations, financial institutions, and other global organizations.She has servedas a board member of several high-growth technology companies. As Coinbase’s first independent director, she was an early architect of company’s global regulatory strategy, serving through its direct listing and subsequent growth as a publicly traded company. During her tenure from 2017 to 2024, she held several positions including Chair of the Nomination and Governance Committee, Chair of the Audit and Risk Committee, and member of the Compensation Committee.Katie joined Andreessen Horowitz as a General Partner in 2018. There, she co-led their crypto franchise, building a team and investing out of three successive funds with billions under management, generating significant realized returns for institutional investors.Before her venture career, Katie spent over a decade as a federal prosecutor with the U.S. Department of Justice. She secured successful jury verdicts in every case she tried and led high-profile prosecutions related to the Silk Road task force, the 2012 Hells Angels murder trial, and the Nuestra Familia prison gang RICO takedown. She also led cyber, corporate, and violent crime investigations in partnership with the FBI, Homeland Security, SEC, and Treasury. At DOJ headquarters, she held senior leadership positions in the National Security Division and later the Attorney General’s office where her portfolio covered antitrust, tax, and national security matters. Katie represented DOJ on both CFIUS and the FBI’s Undercover Review Committee, that approved significant undercover operations.Katie has been profiled by Bloomberg, Fortune, The New York Times, and CNBC and was named one of Bloomberg BusinessWeek’s 50 Most Influential in 2022.
Show more...Investment focus
- Industry: Blockchain, Financial Services, FinTech
- Stage:Seed, Series A
- Geography: United States, United Kingdom
Investor stats
- Total investments: 23
- Round size: Seed $4.5M–$200M; Series A $15M–$55M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- dub — The first Copy-Trading platform for stocks. Copy anyone's investments. For free. Regulated Broker-Dealer member FINRA and SIPC & FDIC insured.
- Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.
- Coinbase Token Manager — LiquiFi helps crypto companies automate token vesting, issue token grants in compliance, and manage their token cap table.
Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 145
- Round size: Seed $1.3M–$8.2M; Pre-Seed $1.5M–$4M; Series A $5.3M–$30M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Mason America, Inc. — Mason is the device innovation platform for product leaders who dare to deliver the next innovation in their field.
- Cara — Cara is a domain-specific AI platform purpose-built for insurance—a modular system that enables agencies, brokerages, and MGAs to automate servicing, accelerate sales, and scale operations with a 24/7 digital workforce.
- Metaplane — Metaplane is a data observability platform that helps data teams know when things break, what went wrong, and how to fix it.
Peter Harris
Show more...Investment focus
- Industry: Life Science, Biotechnology, Health Diagnostics
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $2.4M–$5M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- CND Life Sciences — CND advances neurodiagnostics through skin biopsy testing, including the Syn-One Test, for neurodegenerative diseases.
Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 32
- Round size: Seed $4M–$117M; Pre-Seed $1M–$11M; Series A $17M–$156M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- FlyMy.AI — Real-time AI cloud
- Medra AI — Building robotics to accelerate scientific breakthroughs. At Medra, our mission is to automate repetitive wetlab tasks so scientists can more easily collect data and run the experiments needed to make groundbreaking scientific discoveries.
- Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.
Ankit Jain is the Founder and CEO of Infinitus Systems.
Show more...Investment focus
- Industry: Health Care, Medical, Hospital
- Stage:Seed, Pre-Seed
- Geography: United States
Investor stats
- Total investments: 6
- Round size: Seed $75k–$3.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Advex AI — Composer is a no-code AI vision system that enables industrial teams to train, deploy, and manage complex visual inspection tasks across manufacturing lines. Composer uses VLMs and synthetic data to achieve production performance in minutes.
- RapidClaims — Rapid Claims helps businesses autonomously code medical charts, find up-coding opportunities, improve the CDI process and reduce denials.
- Empower Sleep — Empower Sleep provides personalized sleep care online
Lars Fjeldsoe-Nielsen grew up across Africa, from Angola and Guinea-Bissau to Tanzania and Libya, after his family fled the Angolan Civil War as refugees. Those early experiences instilled in him a belief that education, technology, and social innovation can transform lives and continue to anchor his career and philanthropic activities to this day.Today, Lars is a General Partner at Owl Ventures ($2.2 billion AUM), the world’s leading venture capital firm focused exclusively on education technology. He leads Owl’s expansion across Europe, Africa, and global markets, backing founders who harness AI and breakthrough technologies to make learning more accessible and impactful.Before joining Owl, Lars co-founded 2xN, an early-stage fund at the frontier of deeptech and quantum innovation, with standout investments including Quantinuum (valued above $10 billion), Oxford Ionics (acquired by IonQ in a $1 billion deal), QSimulate, and Sparrow Quantum. Prior to that, he was a General Partner at Balderton Capital in London during which time the firm led the Seed and Series A rounds in Revolut. His investments also span education (Labster, uLesson, StudySmarter, Kukua), mobility (Yassir, Voi, Monta, NoTraffic), and mobile and frontier tech (Hiya, Monarch Money, Rahko, Pocket, Colossal, Celus, Octant Bio, Vivino, OpenSea, Blue Bottle Coffee).Lars previously spent a decade in Silicon Valley, shaping some of tech’s most iconic growth stories. At Uber, he joined when it operated in fewer than 20 cities and, as Vice President, forged global alliances with Verizon and América Móvil that fueled its international expansion. Before Uber, as Head of Mobile at Dropbox, he was among the first 25 employees and helped the company reach its first 100 million users through partnerships with Samsung and other OEMs.Despite his career in technology and venture capital, Africa has never left Lars’s journey. After his father’s passing, he returned to Angola to trace his family’s history, discovering that his sister had died of malaria as a child. That revelation transformed a personal loss into a mission. A technologist turned humanitarian innovator, Lars filed a patent for genetically modified mosquitoes that light up when carrying malaria and began funding malaria-research projects in Angola through partnerships with global nonprofits. In 2024, he climbed Mount Kilimanjaro to raise funds for malaria research, following earlier campaigns such as climbing the Matterhorn and crossing the Sahara by motorbike.A Danish-Portuguese national who served with the Royal Danish Guards, Lars holds an MBA from London Business School, where he was a member of the Board of Governors and Chairman of the Endowment Fund, an MSc from Oxford University (Keble College), and a BSc from King’s College London. Across every chapter, from refugee to technologist to investor, his purpose endures: advancing education, health, and innovation as catalysts for social change.
Show more...Investment focus
- Industry: Software, Information Technology, Mobile Apps
- Stage:Seed, Series A, Series B
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 69
- Round size: Seed $1.8M–$10M; Series A $4M–$48M; Series B $9.6M–$163M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Blue — An Operating System for your Personal Health. Join the waitlist here.
- UrbanKisaan — UrbanKisaan builds vertical farms in India and sells the produce directly to consumers via subscription based app. The farms create a positive change at every step from seed to store ensuring quality and traceability. They grow fresh veggies locally produced which are grown without using soil using 95% less water. It aims to create a sustainablefuture for farming and feed the world in a way that is good for both people and the planet.It was founded in 2017 and is headquartered in Hyderabad, Andhra Pradesh, India.
- Colossal Biosciences — The science of genetics. The business of discovery.
CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.
Show more...Investment focus
- Industry: Robotics, E-Commerce, SaaS
- Stage:Series A, Seed, Series D
- Geography: United States
Investor stats
- Total investments: 18
- Round size: Seed $3.7M–$9.7M; Series A $5M–$27M; Series D $80M–$150M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.
Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 67
- Round size: Seed $1.4M–$6.3M; Pre-Seed $1.5M–$2.3M; Series A $3M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
- Crosby — Crosby is a company with programmers from Ramp, Vanta, Meta, and Google joining attorneys.
- Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $3.6M–$4.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
- Spring Discovery — Giving Scientists AI Superpowers
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Patrick Collison is a CEO of Stripe.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series C
- Geography: United States, United Kingdom, Ireland
Investor stats
- Total investments: 72
- Round size: Seed $2.7M–$13M; Series A $10M–$105M; Series C $20M–$170M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Centivax — Centivax is a healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services.
- The Interaction Company of California — The proactive AI assistant in your iMessage, WhatsApp, and more. Texts like a human, really knows you, and integrates with your life in dozens of ways.
- SendCutSend — SendCutSend is an online custom manufacturing service specializing in rapid, high-precision sheet metal fabrication and CNC machining. Customers simply upload their digital design files to get professional-grade parts manufactured and shipped to their door, with turnaround times as fast as 24 hours.
Patrick Yang, General Partner at Amity Ventures, has led the firm’s investments in CaptivateIQ, Evisort, Flick, MoQuality, TruePill, and Vowel. He sits on the boards of Evisort and MoQuality. His primary areas of investment focus include AI, consumer, logistics, mobility, and software. Patrick co-founded Amity Ventures with CJ Reim in 2017 afterthe two worked together at Highland Capital Partners.Prior to Amity, Patrick was a Vice President at Highland, where he sourced the firm’s investment in nuTonomy, an autonomous vehicle startup acquired by Delphi one year later for $450M. Patrick is from the Bay Area and holds a B.S. in Business Administration with a concentration in Engineering Leadership from University of California, Berkeley.Pat currently serves on the board of Advancing Women in Product, a non-profit that empowers women to enter and succeed in product management roles. In his free time, he enjoys hiking and eating in the San Francisco area, and attending sporting events—especially Warriors, 49ers, and Giants games.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: United States
Investor stats
- Total investments: 32
- Round size: Seed $2.5M–$4.5M; Series A $5M–$16M; Series B $35M–$50M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Innerwell — Innerwell combines personalized guidance from licensed therapists like you with the expansive power of psychedelics to treat anxiety and depression.
Alec Nielsen is the Founder & CEO at Asimov.
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Germany
Investor stats
- Total investments: 6
- Round size: Seed $3M–$16M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cache — Biomolecules are the next bits of the 21st century. So we're developing the first wet operating system for storing, accessing, and computing biomolecules at scale to make them widely accessible and useful. We're enabling the storage and access to the whole data universe—digital and biological—forever so that we don't have to deleteor dispose of anything ever again.
- Lamin — Lamin provides an open data platform for biology, enabling tracked data management, streamlined collaboration, and learning at scale.
- General Proximity — General Proximity is a pioneering future-oriented proximity medicine that envisions the future of medicine.
Sridhar Iyengar is based out of Cambridge, Massachusetts, and is the Founder, CEO, Chief Strategy & Technology Officer, and Chairman of Elemental Machines. Sridhar previously worked at Misfit Wearables as Founder, CTO, and Director. Sridhar Iyengar attended the University of Cambridge.
Show more...Investment focus
- Industry: B2B, Events, Travel
- Stage:Seed, Angel, Pre-Seed
- Geography: United States
Investor stats
- Total investments: 7
- Round size: Seed $470k–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Stedi — Stedi is the only programmable healthcare clearinghouse. We offer modern, AI-ready APIs for eligibility checks, claims, transaction enrollment, and more.
- Fuel — Rumtar88slot pilihan tepat pecinta slot, bonus member, cashback, turnamen, dan keamanan berlapis untuk bermain nyaman.
- Trilobio — Biology is the future, but most lab technology is stuck in the past. Trilobio is rebuilding the biology lab from the ground up to unlock its true potential.
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 61
- Round size: Seed $537k–$25M; Series A $4.1M–$50M; Series B $1.6M–$56M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Craig Mundie is chief research and strategy officer of Microsoft Corp., reporting to CEO Steve Ballmer. In this role, he oversees Microsoft Research, one of the world’s largest computer-science research organizations, and is responsible for Microsoft’s long-term technology strategy. Mundie also directs a number of technology incubations, and workswith government and business leaders around the world on technology policy, regulation and standards.Mundie has spent much of his career building startups in various fields, including supercomputing, consumer electronics, education, healthcare and robotics. He joined Microsoft in 1992 to create and run the Consumer Platforms Division, which developed non-PC platforms such as the Windows CE operating system; software for the Handheld PC, Pocket PC and Auto PC; and early console-gaming products. Mundie also started Microsoft’s digital-TV efforts, acquiring and managing its WebTV Networks subsidiary, and built its fast-growing healthcare solutions business.Prior to his current role, Mundie served as Microsoft’s chief technical officer for advanced strategies and policy, working with Microsoft Chairman Bill Gates to develop the company’s global strategies around technical, business and policy issues. Another long-standing focus for Mundie is privacy, security and cyber-security. He initiated Microsoft’s Trustworthy Computing initiative, which has leveraged new software-development practices to significantly improve the security of the company’s products.For more than a decade, Mundie has also been Microsoft’s principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009 Mundie was appointed by President Barack Obama to the President’s Council of Advisors on Science and Technology.Mundie started his career in 1970, working on operating-system development for the Data General NOVA at Systems Equipment Corp. (SEC) while still studying at Georgia Tech. SEC was subsequently acquired by Data General Corp., where Mundie went on to develop the INFOS data-management system. In 1977 Mundie moved to Data General’s advanced development facility in Research Triangle Park, N.C., ultimately becoming its director. In 1982, Mundie was one of three co-founders of Alliant Computer Systems Corp., which developed vector-parallel mini-supercomputers. He held a variety of positions at Alliant before becoming CEO. The company shut down in 1992.Mundie holds a bachelor’s degree in electrical engineering and a master’s degree in information theory and computer science from Georgia Tech. Mundie enjoys traveling and spending time on his boat. He is married, with one married daughter.
Show more...Investment focus
- Industry: Life Science, Chemical, Genetics
- Stage:Seed, Series B, Series C
- Geography: United States
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
- Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.
Show more...Investment focus
- Industry: Software, Blockchain, Internet
- Stage:Seed, Series A
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 85
- Lead/follow: no public data
Portfolio highlights
- Key — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
- Matic — The world's most advanced floor cleaner. Your home's best helper.
- Bluenote Health — Accelerate innovation with AI built for and trusted by leading life sciences companies.
David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.
Show more...Investment focus
- Industry: Biotechnology, Genetics, Life Science
- Stage:Seed, Series A, Series B
- Geography: United States
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
- Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
- Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Joshua Elkington
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $2.6M–$2.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
- Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Aiden Ross
Show more...Investment focus
- Industry: Consulting, Life Science, Neuroscience
- Stage:Seed, Pre-Seed
- Geography: United States
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Spike Neuro — Behind Spike Neuro is a team of researchers who know a lack of good ideas is not one of the limitations to advancing neuroscience. Frustrated with seeing exciting technology that could help researchers, clinicians, and patients placed on a shelf, we are working to provide innovators with the guidance, resources, and infrastructure for successfulcommercialization of neurotechnology.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Japan
Investor stats
- Total investments: 99
- Round size: Seed $2.5M–$35M; Pre-Seed $450k–$2.3M; Series A $10M–$60M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Terraton — Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.
- Moonlake AI — Vibe code games and worlds into existence.
- Belfort — Belfort is specialising in technology that accelerates encrypted data processing, allowing it to be done in real time without ever decrypting the data.
Considered one of the fathers of science & technology strategic communications - founded Technology Solutions, Inc. in 1983. Client list read like a who's who list of startup technology companies in computing, communication, software, education, and entertainment. Maintained a strategic communications partnership with Sony & IBMCorporation (10 years). Received the Gold CIPRA award in 1998 for the IBM Deep Blue/Gary Kasparov Chess Match. In 1996, TSI was recognized as the #1 fastest growing agency in the United States. Sold the company to The McCann Erickson World Group in 1997 and became the Vice Chairman. Created Focus Technology, an organization that provided qualitative research and instituted the RPM model of integrated strategic communications providing ultra-competitive technology clients the ability to quickly discover and leverage their key strengths as well as mitigate their destructive weaknesses.Brian was a pioneer in the founding of a number of the first computing publications including Computer Systems News and InformationWeek magazine. Now serves as Chairman of the New York Angels. He is very devoted to the New York City startup community.Developed the AIMS (Applied Internet Media Studies) Program, a senior/graduate level college semester program where students will be rigorously trained to use the internet professionally.Frequent speaker on strategic communication, entrepreneurism and early startup investing. Now writing a book for McGraw Hill - a new organizational product launch model.Received the Distinguished Alumnus Award, holds a Masters Degree in Science Communications from Boston University's School of Communications.
Show more...Investment focus
- Industry: Software, SaaS, Mobile
- Stage:Seed, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 47
- Round size: Seed $300k–$2.5M; Series A $1.2M–$12M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
- CourseHorse — CourseHorse is a provider of a learning platform used to centralize the learning opportunities. Its platform partners with providers of Spanish lessons, cooking courses, yoga classes, and other classes to create a single destination for people seeking personal interest education that enables people to increase ease and confidence in discovering thepath to personal enrichment.It was founded in 2011 and is headquartered in New York.
- Boundless Mind — Thrive Global's mission is to end the burnout epidemic with sustainable, science-based solutions that unlock employee performance and enhance well-being through our behavior change technology.
Sujay Jaswa is founder and managing partner at WndrCo, a holding company that invests in and acquires consumer technology businesses. He serves as Chairman of Aura, Twingate, VPN Super, and is a Director of The Infatuation. Board member of Vy Global Growth (Nasdaq: VYGG). Advisor at Seven1 Sports & Entertainment Agency. He is also a lecturerat the Stanford Graduate School of Business. He formerly served as business founder, vice president of business, and CFO of Dropbox from 2010 to 2015. At Dropbox, Sujay created and led the global business and finance organization. He has a Bachelor’s degree in Economics from Princeton University and an MBA from Harvard Business School.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series B, Series A
- Geography: United States, Spain, Germany
Investor stats
- Total investments: 30
- Round size: Seed $1.8M–$10M; Series A $11M–$200M; Series B $15M–$85M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Dance — Dance is an electric mobility subscription company that makes it easy to explore your city with an electric bike or moped.
- point.me — Search and book award flights and maximize the value of your points. Travel on points for less with point.me's flight award search tool.
- Varo Bank — Get access to personal banking services including no monthly fee checking, high-yield savings, cash advances up to $250 and more with Varo Bank.
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.
Show more...Investment focus
- Industry: Blockchain, Software, Cryptocurrency
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Singapore
Investor stats
- Total investments: 257
- Round size: Seed $2.3M–$15M; Pre-Seed $665k–$4.5M; Series A $6M–$31M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- BizScout — BizScout is an online platform of Off market deals for verified buyers and sellers.
- Collektr — Collektr is a live streaming community marketplace where users can buy, sell, and exchange collectible things in a secure environment. It's also a gathering place for keen collectors to discuss their common interests in a wide range of products and categories.
- M1X Global — M1X unlocks new applications of blockchain technology across public sector programs and institutional markets. We partner with governments to identify opportunities, coordinate expertise and support long-term economic development.
Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University.
Show more...Investment focus
- Industry: Biotechnology, Genetics, Life Science
- Stage:Series A
- Geography: United States
Investor stats
- Total investments: 3
- Round size: Series A $30M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kytopen — Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.
- Erbi Biosystems — Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
- 64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.
James Hong
Show more...Investment focus
- Industry: E-Commerce, Mobile, Internet
- Stage:Seed, Series A, Angel
- Geography: United States
Investor stats
- Total investments: 29
- Round size: Seed $100k–$3.7M; Angel $975k–$3M; Series A $1M–$25M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Deep Infra — Deep Infra offers cost-effective, scalable, easy-to-deploy, and production-ready machine-learning models and infrastructures for deep-learning models.
- Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
Nitesh Banta is the Co-Founder & CEO at B12.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 104
- Round size: Seed $1.3M–$16M; Pre-Seed $500k–$2.5M; Series A $6.5M–$24M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Pelgo — Pelgo is a startup that provides AI-powered career transition services. For employees coming out of layoffs, young grads just entering the job market, or full-time professionals trying to adjust to a developing AI-driven economy, its tools, along with human advisors, help onboarding, transition, and reskilling.
- howie — howie an email-based scheduling assistant, uses artificial intelligence to automate the scheduling and rescheduling of your meetings.
- Self Protocol — Self is spearheading a secure, human-first internet by allowing users to verify their identities while maintaining their privacy. Self Protocol is an identity and proof-of-humanity solution that uses zero-knowledge technology to confirm personhood and distinctive traits, like age and nationality, without revealing private information.
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 252
- Round size: Seed $1.6M–$20M; Series A $9.5M–$50M; Series B $28M–$117M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- NavigateAI — NavigateAI is an AI copilot for the physical world specifically designed for construction and field service teams to help them complete projects faster, with higher quality, and at lower costs.
- Harvey — Harvey is an artificial intelligence technology service provider.
- Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Blockchain
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 186
- Lead/follow: no public data
Portfolio highlights
- Yendo — Our mission is to provide everyone with the most accessible, most affordable, and most transparent credit by leveraging their vehicles.
- TransCrypts — We all have that file box where we throw all our important documents. Our goal at TransCrypts is to make that box digital and have all the documents secured through the blockchain. We currently offer industry leading privacy and security standards on our file storage and sharing platform and have solutions for individuals all the way to enterprises.
- FORT Robotics — FORT Robotics enables OEMs & end users to build and operate smart machines safely and securely, while maximizing productivity and reducing risks.
Vinny Lingham is Co-Founder & CEO at Civic. He was the founder and CEO of Gyft, a mobile gift card app that allows customers to buy, store, send and redeem gift cards conveniently from their mobile device. He is also the founder of Yola.com, a web development and hosting company that enables users without prior programming knowledge to developwebsites. Vinny is the recipient of numerous awards, including Top Young ICT Entrepreneur in Africa (2006) and was also a finalist for Men’s Health Best Man (2009) and ICT Personality of the Year in South Africa (2008). He also previously founded Clicks2Customers, which also won the Top Technology Company award in South Africa in 2006. He has previously served on marketing advisory boards for Nasdaq listed Valueclick and Yahoo, was also selected as an Endeavor “High Impact Entrepreneur” in 2006. Vinny studied a B.Com (Information Systems) at the University of Cape Town.
Show more...Investment focus
- Industry: Blockchain, Internet, Cryptocurrency
- Stage:Seed, Angel
- Geography: United States, South Africa, United Kingdom
Investor stats
- Total investments: 35
- Lead/follow: no public data
Portfolio highlights
- TipLink — TipLink helps send crypto with a link. Someone with crypto can create a account and send that link to anyone over any platform. It’s like buying a gift card, connect the client's crypto wallet of choice and create a account by depositing how much they want to send.
- Afterparty — Your favorite creators are here! Get 1 on 1 unfiltered experiences with creators through Afterparty livestreams or chat 24/7 through AI powered conversations
- Collectibles.com — Collectibles.com is a Web3 community and marketplace for collectors and the worldwide collectibles sector.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Aaron Levie is Chief Executive Officer, Cofounder and Chairman at Box, which he launched in 2005 with CFO and cofounder Dylan Smith. He is the visionary behind the Box product and platform strategy, incorporating the best of secure content collaboration with an intuitive user experience suited to the way people work today. Aaron leads the companyin its mission to transform the way people and businesses work so they can achieve their greatest ambitions. He has served on the Board of Directors since April 2005.Aaron attended the University of Southern California from 2003 to 2005 before leaving to found Box.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Czech Republic
Investor stats
- Total investments: 53
- Lead/follow: no public data
Portfolio highlights
- Pika — The idea-to-video platform that sets your creativity in motion.
- Retell AI — RetellAI is an API for creating human-like conversational voice AI. Developers can build a voice AI similar to JARVIS in just a day — with an ~800ms response time and the ability to handle interruptions.
- Better Stack — Delightful observability tools that turn your logs & monitoring into a secret weapon for shipping better software faster.
Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs anddiscovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.
Show more...Investment focus
- Industry: Biotechnology, Cannabis, Biopharma
- Stage:Seed
- Geography: United States, Canada
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Epinoma — Epinoma is a diagnostics company that focuses on the multi-omics approach to cancer monitoring. It engineers proteins that control the operating system of biology. The company was founded in 2020 and is headquartered in San Francisco, California.
- BluumBio — BluumBio develops next-generation remediation technologies that clean up pollution and restore degraded ecosystems
- Promakhos Therapeutics — A Boston-based biotech startup developing therapeutics.
CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom
Investor stats
- Total investments: 15
- Lead/follow: no public data
Portfolio highlights
- Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
- Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
- Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Daniel M. Bradbury is Director at Liquid Grids.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Seed, Series A
- Geography: United States
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Alume Biosciences — Alume is a biotechnology company, developing nerve-targeted pharmaceutical agents for surgical and therapeutic use. The company's first product, ALM-488, is a fluorescently labeled peptide-dye conjugate that makes human nerves "glow," helping surgeons reduce injury to critical nerves during surgery. During surgery, inadvertentinjury to nerves leads to loss of function, including paralysis, numbness, and decreased quality of life. Alume intends to develop agents including ALM-488 to be used as an adjunct during surgery to help surgeons see nerves better compared to current visualization with white light alone. Alume's technology has the potential to improve the accuracy of nerve identification, decrease operative time, and lead to better outcomes for patients.
- Amplo Biotechnology — Amplo Biotechnology is a gene therapy company focused on the neuromuscular junction
Paul B. Manning has served as the chairman of our board of directors since December 2017 and as a member of our board of directors since December 2015. Mr. Manning is the Chairman and Chief Executive Officer of PBM Capital Group, LLC, a private equity investment firm in the business of investing in healthcare and life-science related companies,which he founded in 2010. Prior to that, Mr. Manning founded PBM Products in 1997, a producer of infant formula and baby food, which was sold to Perrigo Corporation in 2010. Mr. Manning is a director of Dova Pharmaceuticals, Inc., a publicly traded pharmaceutical company, as well as various private companies. Mr. Manning was previously on the board of directors of Perrigo Corporation, Concordia Healthcare Corp. and AveXis, Inc. Mr. Manning received a B.S. in microbiology from the University of Massachusetts.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Medical
- Stage:Series A, Series B, Post-IPO Equity
- Geography: United States
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- Kriya Therapeutics — Kriya is a next-generation gene therapy company focused on designing and developing transformative new treatments for highly prevalent and severe chronic diseases. We target conditions where the underlying biology is well-understood, rationally designing one-time gene therapies to durably express therapeutic proteins within the appropriate humantissues. Our team has deep expertise in the field and includes former senior leadership from pioneering gene therapy companies and academic institutions. We use algorithmic tools, scalable infrastructure, and proprietary technology to optimize the efficacy and durability of our gene therapies – with a goal of transforming the treatment paradigm for some of the most serious and widespread diseases.
- Liquidia Technologies — Liquidia Technologies is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed toimprove the safety, efficacy, and performance of a wide range of therapies. Currently, Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. In addition to developing our own product candidates, Liquidia collaborates with leading pharmaceutical companies to apply our PRINT technology across a wide range of therapeutic areas, molecule types, and routes of administration.
- The Paul and Diane Manning Institute of Biotechnology — The Paul and Diane Manning Institute of Biotechnology engages in the medical research that leads to new medical treatments, including cellular therapy, gene therapy, nanotechnology and drug delivery.
Angela Jackson is an active angel investor and coach to emerging companies and entrepreneurs. Her background is in marketing/sales, strategy, fundraising and leadership. In addition to her role as the Portland/Oregon Keiretsu Forum Chapter President, Angela is also Managing Director & Fund Manager at Bridge City Ventures Portland SeedFund, Manager of the Portland State University Business Accelerator, an investor in Oregon Angel Fund and co-chair of Angel Oregon’s Consumer/Active Lifestyle investment track and serves on the company selection committee for Women’s Investment Network. Angela also advises nonprofit/social entrepreneurs and recently was an “Ask the Expert” consultant to Craigslist Foundation social entrepreneurs in New York. She is an advisor/investor with Mercy Corps’ Phoenix Fund, which helps microenterprises in third world areas succeed. Growing up in a family culture of entrepreneurship and philanthropy, she co-founded Social Venture Partners Portland with other area investors in 2001 and has launched numerous non-profit and for-profit enterprises. She held various sales/marketing roles at Auctionpay through Series A and B rounds, a period of rapid growth which earned it numerous awards including a spot on Inc. Magazine 500 fastest growing companies list. Angela loves working with people to help accelerate the success of “the big idea” and is a proud Mom to two budding entrepreneurs, ages 11 and 15.
Show more...Investment focus
- Industry: Local, Internet, Software
- Stage:Convertible Note, Series A
- Geography: United States
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Lish — Lish specializes in corporate catering, office catering, online catering delivery, and workplace food solutions. We serve companies in Seattle & Bellevue/Eastside, including Redmond and Kirkland.
- Chronicled — Automating business rule enforcement in the life sciences industry through the blockchain-powered MediLedger Network
Bill is the Chairman and Co-Founder of the Pear Tree Funds, the President of Pear Tree Investment Advisors, Inc., and the Chairman of U.S. Boston Capital Corporation. He has over 40 years of experience in the finance and investment management business.Bill holds the Chartered Financial Analyst (CFA) designation and is a member of the CFAInstitute and the Boston Security Analysts Society. He obtained his JD from Harvard Law School, an LLM in taxation from Boston University School of Law, a Masters in Personnel Administration from George Washington University, and a BS with distinction from the United States Naval Academy in Annapolis, Maryland.
Show more...Investment focus
- Industry: Analytics, Life Science, Biotechnology
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Thrive Bioscience — Thrive Bioscience enables quantitative biology with advanced live-cell imaging solutions, empowering researchers with data-rich, automated workflows.
Norman Sorensen who is a Class II director, joined the Board of Directors in March 2015. He is a member of the Company’s Finance, Risk Management and Audit Committee. Mr. Sorensen formerly served as chairman of the International Insurance Society, Inc., a professional organization for the insurance industry, from January 2010 until June 2013. Mr.Sorensen has served as a director of the International Insurance Society, Inc. since January 2005. Previously, from November 2011 until December 2012, he was chairman of the International Advisory Council of Principal Financial Group, Inc., a global financial investment management company. He was chairman of Principal International, Inc., serving from June 2011 to October 2012, and president and CEO of International Asset Management and Accumulation of Principal International, Inc., serving from January 2001 to June 2011. Mr. Sorensen has served as a director of Encore Capital Group, Inc., a consumer banking company, since November 2011. Mr. Sorensen also served as a director of Sara Lee Corporation, an American consumer-goods company, from January 2007 to November 2011. He has served as executive vice president of both Principal Financial Group Inc. and Principal Life Insurance Company, a life insurance company, since January 2007, and held a number of other senior management positions since 1998. Mr. Sorensen also served as chairman of the U.S. Coalition of Service Industries, a leading forum for the services sector, from January 2003 to March 2005. Mr. Sorensen served as a senior executive of American International Group, Inc., an insurance services company, from September 1989 to December 1998. He also formerly served as chairman and director of DE Master Blenders, from December 2011 until September 2013.
Show more...Investment focus
- Industry: SaaS, FinTech, Analytics
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Solidus Labs — The first automated, comprehensive and testable market surveillance and risk monitoring hub tailored for digital assets
- Thrive Bioscience — Thrive Bioscience is commercializing a family of instruments and software that provide imaging, analytics, and automation to significantly improve cell culture and the analysis of live cells. Thrive’s instruments empower biologists to deliver consistent, reproducible results by leveraging microscopy, robotics, fluidics, and other fields, to captureimages and data and provide analysis, reports, guidance, documentation, and a database on the cells and on cell culture processes.
Leonardo DiCaprio is an American actor and film producer. He has been nominated for three Academy Awards and nine Golden Globe Awards. He won the Golden Globe Award for Best Actor for his performance in The Aviator (2004), and has been nominated by the Screen Actors Guild, Satellite Awards, and the British Academy of Film and Television Arts. Acommitted environmentalist, DiCaprio has received praise from environmental groups for his activism. At the 2007 Oscar ceremony, DiCaprio and former Vice President Al Gore announced that the Academy Awards had incorporated environmentally intelligent practices throughout the planning and production processes, and on July 7, 2007, DiCaprio presented at the American leg of Live Earth.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Manufacturing
- Stage:Series A, Seed
- Geography: United States, Israel, Switzerland
Investor stats
- Total investments: 34
- Lead/follow: no public data
Portfolio highlights
- Exowatt — Modular full-stack renewable energy solutions for commercial and industrial customers.
- ID Genève — We make watches that reflect the values and principles of people who are committed to fight climate change and who wish to have a positive social and environmental impact. The materials used are circular and have a lower carbon footprint than the industry average.
- SolarMente — SolarMente is a software platform that provides solar hardware, installation, warranties, financing, insurance, and technical support. The company was founded in 2020 and is headquartered in Barcelona, Catalonia.
Noel Hall is the Director of Corporate of Wellcome Trust. He is a former Board Director, Co-founder, and President of Aspreva Pharmaceuticals Corp. He attended the University of London.
Show more...Investment focus
- Industry: Biotechnology, Genetics, Life Science
- Stage:Seed, Angel
- Geography: Canada, United States
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
- Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
Life Science Angel investor funding in United States at a glance
Stats across 239 deals from 335 investors.
Access all 335 angel investors in United States Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Angel Investors in United States investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 335 angel investors investing in United States Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!